TMPRSS2 and prostate carcinoma: A comparison of PSA, PCA3 and TMPRSS2:ERG mRNA signals is shown in Tables 1 and 2 for blood samples from men with advanced prostate cancer that were processed using the dual antibody magnetic particle formulation.